Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Sheehan

Showing results (141-150 of 195) with videos related to

Pageof 20
Sort By:
Human Psychopharmacology|June 18, 2011
Clinical and functional outcomes in patients with major depressive disorder and painful physical symptoms switched to treatment with duloxetineDavid V Sheehan, Pratap R Chokka, Renee E Granger, et al.
Marine Environmental Research|May 18, 2019
Assessing the impact of introduced infrastructure at sea with cameras: A case study for spatial scale, time and statistical powerAnthony W J Bicknell, Emma V Sheehan, Brendan J Godley, et al.
Biological Psychiatry|July 1, 1986
Immunological response to stress in agoraphobia and panic attacksO S Surman, J Williams, D V Sheehan, et al.
Eating and Weight Disorders : EWD|March 5, 2016
A systematic review of the health-related quality of life and economic burdens of anorexia nervosa, bulimia nervosa, and binge eating disorderTamás Ágh, Gábor Kovács, Dylan Supina, et al.
Marine Pollution Bulletin|October 1, 2013
Drawing lines at the sand: evidence for functional vs. visual reef boundaries in temperate Marine Protected AreasE V Sheehan, S L Cousens, S J Nancollas, et al.
CNS Drugs|October 9, 2008
Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disordersDavid V Sheehan, Matthew S Keene, Michael Eaddy, et al.
Human Psychopharmacology|September 3, 2015
Assessment of functional outcomes by Sheehan Disability Scale in patients with major depressive disorder treated with duloxetine versus selective serotonin reuptake inhibitorsDavid V Sheehan, Michele Mancini, Jianing Wang, et al.
Journal of Affective Disorders|June 21, 2016
Brexpiprazole as an adjunctive treatment in young adults with major depressive disorder who are in a school or work environmentRichard H Weisler, Ai Ota, Kana Tsuneyoshi, et al.
International Journal of Psychiatry in Medicine|June 22, 1999
Diagnostic errors of primary care screens for depression and panic disorderA C Leon, L Portera, M Olfson, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|September 15, 2001
Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorderA A Silver, R D Shytle, K H Sheehan, et al.
Pageof 20

Showing results (141-150 of 195) with videos related to

Sort By:
Pageof 20
Human Psychopharmacology|June 18, 2011
Clinical and functional outcomes in patients with major depressive disorder and painful physical symptoms switched to treatment with duloxetineDavid V Sheehan, Pratap R Chokka, Renee E Granger, et al.
Marine Environmental Research|May 18, 2019
Assessing the impact of introduced infrastructure at sea with cameras: A case study for spatial scale, time and statistical powerAnthony W J Bicknell, Emma V Sheehan, Brendan J Godley, et al.
Biological Psychiatry|July 1, 1986
Immunological response to stress in agoraphobia and panic attacksO S Surman, J Williams, D V Sheehan, et al.
Eating and Weight Disorders : EWD|March 5, 2016
A systematic review of the health-related quality of life and economic burdens of anorexia nervosa, bulimia nervosa, and binge eating disorderTamás Ágh, Gábor Kovács, Dylan Supina, et al.
Marine Pollution Bulletin|October 1, 2013
Drawing lines at the sand: evidence for functional vs. visual reef boundaries in temperate Marine Protected AreasE V Sheehan, S L Cousens, S J Nancollas, et al.
CNS Drugs|October 9, 2008
Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disordersDavid V Sheehan, Matthew S Keene, Michael Eaddy, et al.
Human Psychopharmacology|September 3, 2015
Assessment of functional outcomes by Sheehan Disability Scale in patients with major depressive disorder treated with duloxetine versus selective serotonin reuptake inhibitorsDavid V Sheehan, Michele Mancini, Jianing Wang, et al.
Journal of Affective Disorders|June 21, 2016
Brexpiprazole as an adjunctive treatment in young adults with major depressive disorder who are in a school or work environmentRichard H Weisler, Ai Ota, Kana Tsuneyoshi, et al.
International Journal of Psychiatry in Medicine|June 22, 1999
Diagnostic errors of primary care screens for depression and panic disorderA C Leon, L Portera, M Olfson, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|September 15, 2001
Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorderA A Silver, R D Shytle, K H Sheehan, et al.
Pageof 20